<p>The most common adverse reactions (20%) with Erlotinib from a pooled analysis of studies were rash, diarrhea, anorexia, fatigue, dyspnea, cough, nausea, and vomiting. The following serious adverse reactions, which may include fatalities.</p>

<ul>
	<li>Interstitial Lung Disease (ILD)</li>
	<li>Renal Failure</li>
	<li>Hepatotoxicity with or without Hepatic Impairment</li>
	<li>Gastrointestinal Perforation</li>
	<li>Bullous and Exfoliative Skin Disorders</li>
	<li>Myocardial Infarction/Ischemia</li>
	<li>Cerebrovascular Accident</li>
	<li>Microangiopathic Hemolytic Anemia with Thrombocytopenia</li>
	<li>Ocular Disorders</li>
	<li>Hemorrhage in Patients Taking Warfarin</li>
</ul>